Topics

HemoSonics Company Profile

04:08 EDT 16th September 2019 | BioPortfolio

HemoSonics is a medical device company with the goal of improving outcomes and reducing healthcare costs by enabling more targeted selection and dosing of blood products in critical care settings. The company is developing the Quantra™, a point-of-care in vitro diagnostic platform that measures blood clot formation and breakdown and provides actionable information to guide the management of critical bleeding and clotting. HemoSonics seeks to transform the way clinicians manage coagulation dysfunctions by providing comprehensive, timely and accurate information on coagulation status at the point of care, enabling clinicians to rapidly choose the right treatment. HemoSonics’ products are for Research Use Only and are not intended for clinical diagnostic use at the current time. For more information, visit http://hemosonics.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

HemoSonics secures CE Mark for expanded Quantra Hemostasis System

US-based medical devices company HemoSonics has secured CE Mark and commercially rolled out its new QStat Cartridge, an extension of its Quantra Hemostasis System, in Europe and Hong The post HemoSon...

FDA Clears HemoSonics’ Quantra QPlus System, a Rapid Coagulation Diagnostic for Hospital Transfusion Management

Charlottesville, VA – March 13, 2019 – HemoSonics today announced that its innovative Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge have been granted de novo mark...

HemoSonics Registers CE Mark for its New QStat® Cartridge, Expanding the Use of its Innovative Quantra® Hemostasis System to Trauma Surgery and Liver Transplant Settings

HemoSonics is excited to announce that its new QStat Cartridge, an extension of its groundbreaking Quantra Hemostasis System, has registered for CE Mark and is now commercially available in Europe an...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

HemoSonics - UTMB Cardiac Surgery Study

This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the Quantra QPlus Cartridge in patients undergoing cardiac surgery utilizin...

Companies [1 Associated Companies listed on BioPortfolio]

HemoSonics

HemoSonics is a medical device company with the goal of improving outcomes and reducing healthcare costs by enabling more targeted selection and dosing of blood products in critic...

More Information about "HemoSonics" on BioPortfolio

We have published hundreds of HemoSonics news stories on BioPortfolio along with dozens of HemoSonics Clinical Trials and PubMed Articles about HemoSonics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HemoSonics Companies in our database. You can also find out about relevant HemoSonics Drugs and Medications on this site too.

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Palliative Care
Palliative care is the active holistic care of patients with advanced progressive illness. Management of pain and other symptoms and provision of psychological, social and spiritual support is paramount. The goal of palliative care is achievement of the ...


Corporate Database Quicklinks



Searches Linking to this Company Record